Princeton, NJ, April 7, 2010 -Sandoz Inc. announced today the introduction in the US of losartan potassium and losartan potassium-hydrochlorothiazide (HCTZ) tablets, authorized generic equivalents of ...

Daiichi Sankyo has presented new data showing that Benicar is superior to Merck & Co's now off-patent Cozaar in reducing blood pressure. Daiichi Sankyo has presented new data showing that Benicar is ...

Teva Pharmaceutical Industries has been given the go-ahead in the USA for its generic versions of Merck & Co's blockbuster antihypertensives Cozaar and Hyzaar. Teva Pharmaceutical Industries has been ...

Jerusalem, March 2, 2010- Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that the U.S. Court of Appeals for the District of Columbia Circuit has ruled in Teva's favor by overturning ...

WASHINGTON The Food and Drug Administration has granted approval to Aurobindo Pharma to manufacture and market losartan potassium tablets in 25 mg, 50 mg and 100 mg strengths, according to FDA ...

A higher dose of the angiotensin receptor-blocker losartan (Cozaar, Merck) was associated with a reduction in all-cause mortality and HF hospitalization, according to new study results. Researchers ...

A common drug that is used to treat high blood pressure in the general population has been found to significantly reduce a dangerous and frequently fatal cardiac problem in patients with Marfan ...

Jan. 7, 2003 — A U.S. Food and Drug Administration (FDA) advisory committee has recommended that losartan (Cozaar), an antihypertensive agent marketed by Merck, be approved for the prevention of ...

PITTSBURGH The Food and Drug Administration has approved two generic drugs by Mylan for treating hypertension, Mylan said Friday. The company announced the approval of losartan potassium and ...